首页> 外国专利> METHOD OF MANUFACTURE OF NOVEL N-ALKYLATED DERIVATIVES OF 2-AMINOETHANOL 2-AMINOEHTANOLA

METHOD OF MANUFACTURE OF NOVEL N-ALKYLATED DERIVATIVES OF 2-AMINOETHANOL 2-AMINOEHTANOLA

机译:一种新的N-烷基化的2-氨基戊醇2-氨基戊醇衍生物的制备方法

摘要

The invention relates to novel N-alkylated aminoalcohols of the formula IMAGE (I) in which Ar is a radical of aromatic character which is unsubstituted or substituted by hydroxyl, n has the values nought or 1 and Alk is an alkylene radical having 2 to 5 carbon atoms and the nitrogen atom and the oxygen atom or, if n is nought, the salicylamide radical are separated from one another by at least two carbon atoms in the straight-chain, and their salts. The main action of the novel compounds consists in a stimulation of cardiac beta -receptors; the compounds also effect a blockage of adrenergic alpha -receptors and a lowering in the blood pressure. They can therefore be used as beta -stimulators, especially as agents having a positively inotropic action for the treatment of cardiac insufficiency. Compounds of the formula I in which Ar is phenyl, unsubstituted or substituted by 1 or 2 hydroxyl groups, Alk is an alkylene radical having 2 to 4 carbon atoms, n has the value 1, and the nitrogen atom and the oxygen atom are separated from one another by at least 2 carbon atoms in the straight-chain, or salts thereof, exhibit effects on the central nervous system, which are reflected for example in the suppression of the symptoms of impaired sympathetic functions and in the suppression of lack of initiative. Such compounds of the formula I therefore can be used for the treatment of reactive or endogenic states of depression of varying degrees of severity, and also for the treatment of neurotic or other psychic disturbances involving loss of initiative and depressive disorders. Such compounds can also be used for the short-term treatment of post-partum or postoperative depression, or of depression of different origin. Such compounds of the formula I can be used on their own or in combination with other antidepressants.
机译:本发明涉及式(I)的新型N-烷基化氨基醇,其中Ar是未被取代或被羟基取代的芳族基团,n为零或1,Alk为具有2的亚烷基碳原子数为5的碳原子,氮原子和氧原子,或者如果不为n,则水杨酰胺基团通过直链中的至少两个碳原子及其盐彼此隔开。新化合物的主要作用在于刺激心脏β受体。这些化合物还影响肾上腺素α受体的阻滞和降低血压。因此它们可以用作β-刺激剂,特别是用作具有正性肌力作用的药物以治疗心脏功能不全。式I的化合物,其中Ar是苯基,未被取代或被1或2个羟基取代,Alk是具有2-4个碳原子的亚烷基,n的值为1,并且氮原子和氧原子与直链中的至少两个碳原子或其盐彼此之间表现出对中枢神经系统的作用,这反映在例如抑制交感功能受损的症状和抑制缺乏主动性上。因此,这种式I的化合物可用于治疗严重程度不同的抑郁症的反应性或内源性状态,也可用于治疗涉及丧失主动性和抑郁性疾病的神经性或其他精神障碍。这样的化合物也可用于短期治疗产后或术后抑郁症或不同来源的抑郁症。这样的式I化合物可以单独使用或与其他抗抑郁药组合使用。

著录项

  • 公开/公告号PL117155B1

    专利类型

  • 公开/公告日1981-07-31

    原文格式PDF

  • 申请/专利权人

    申请/专利号PL19790222397

  • 发明设计人

    申请日1979-06-04

  • 分类号C07C103/26;

  • 国家 PL

  • 入库时间 2022-08-22 16:05:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号